Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,61 USD | +0,90% | +1,81% | -15,26% |
22/03 | TELA BIO, INC. : Piper Sandler herhaalt koopadvies | ZM |
21/03 | Transcript : TELA Bio, Inc., Q4 2023 Earnings Call, Mar 21, 2024 |
Omzet 2024 * | 74,87 mln. 69,36 mln. | Omzet 2025 * | 93,8 mln. 86,9 mln. | Marktkapitalisatie | 138 mln. 128 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -47 mln. -43,54 mln. | Nettowinst (verlies) 2025 * | -37 mln. -34,28 mln. | EV/omzet 2024 * | 1,85 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,47 x |
K/w-verhouding 2024 * |
-3,06
x | K/w-verhouding 2025 * |
-4,08
x | Werknemers | 227 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,5% |
Recentste transcriptie over TELA Bio, Inc.
1 dag | +0,90% | ||
1 week | +1,81% | ||
Lopende maand | -17,01% | ||
1 maand | -19,97% | ||
3 maanden | -10,81% | ||
6 maanden | -28,54% | ||
Lopend jaar | -15,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Antony Koblish
FOU | Founder | 58 | 17-04-12 |
Roberto Cuca
DFI | Director of Finance/CFO | 57 | 27-09-21 |
Marissa Conrad
CTO | Chief Tech/Sci/R&D Officer | - | 24-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lisa Colleran
BRD | Director/Board Member | 66 | 20-04-20 |
Douglas Evans
CHM | Chairman | 59 | 20-04-20 |
Antony Koblish
FOU | Founder | 58 | 17-04-12 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 36 M€ | +4,74% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 5,61 | +0,90% | 61 046 |
26-03-24 | 5,56 | +2,21% | 98 913 |
25-03-24 | 5,44 | -5,06% | 104 160 |
22-03-24 | 5,73 | +7,10% | 247 343 |
21-03-24 | 5,35 | -2,90% | 236 564 |
uitgestelde koers Nasdaq, 27 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,26% | 138 mln. | |
+3,10% | 197 mld. | |
+5,51% | 115 mld. | |
+1,11% | 71,22 mld. | |
+12,40% | 53,77 mld. | |
+19,12% | 48,75 mld. | |
+6,87% | 44,22 mld. | |
+11,92% | 28,85 mld. | |
+10,13% | 28,57 mld. | |
+9,52% | 27,62 mld. |